TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Two patients whose care had been denied or restricted obtained approval after taking their cases to insurance company leaders, according to a MedPage Today report published Oct. 8, 2026. The examples suggest that executive escalation can attract attention, but they do not establish how often the tactic succeeds or remove the need for ordinary appeals.
Two patients obtained insurance approval for care after emailing senior company leaders about disputes that had not been resolved through ordinary channels, according to a MedPage Today report published October 8, 2026. The accounts, highlighted by former insurance executive Wendell Potter, suggest that taking a case to the C-suite may prompt attention, but two cases do not establish how frequently the tactic works.
One case involved Elizabeth Nicholas, who was diagnosed with breast cancer at age 36. After months of treatment, her insurer declined to cover the type of chemotherapy her oncologist recommended, the report said. Nicholas emailed the company’s CEO and soon received a message from its chief scientific officer saying the treatment had been approved. Her experience had also been written about by Vanity Fair the previous month, making it a case that had drawn journalistic attention.
The second patient, Donald E. Grant Jr., 49, had severe congenital cervical stenosis. After an earlier two-level artificial disc replacement did not adequately decompress his spinal cord, he later developed myelomalacia, the report said. Grant had surgery scheduled with Hyun Bae, a Cedars-Sinai spine surgeon whom Grant’s appeal described as an expert on his condition. Bae was out of network even though the other parts of the operation were in network.
Grant used the AI-assisted appeal platform Claimable to help prepare an 11-page medical and legal appeal. It argued that his insurer had no in-network surgeon with comparable qualifications and asked that algorithms not be used to decide his case. He sent the appeal to UnitedHealth Group’s CEO and copied other company leaders, legislators and journalists. UnitedHealthcare then approved the procedure with Bae at the in-network rate, according to MedPage Today.
Executive Appeals Can Change Outcomes
The cases matter to patients facing denied or restricted care because they show that some disputes can reach decision-makers beyond the usual claims process. Potter told MedPage Today that large insurers have staff who handle high-profile matters sent to the C-suite or public-relations offices. In his account, cases that attracted media attention when he worked at Cigna received elevated review. That is his description of company practice, not evidence that every insurer handles appeals the same way.
The report does not show that emailing an executive replaces formal appeals, guarantees a favorable decision or works for most people. Both patients had put substantial effort into understanding and documenting their disputes. The examples instead highlight how access to time, expertise, publicity or assistance with an appeal may affect a patient’s ability to escalate a case.
Potter also warned that the approach may carry risks for clinicians who repeatedly challenge insurers. He said a doctor could irritate an insurer and potentially be removed from its network. Patients and providers weighing escalation therefore face a practical question: how to advocate forcefully while considering the possible effect on their coverage or professional relationship.
AI-assisted medical appeal platform
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Two Appeals Reached Leaders
Potter, a former insurance company executive, featured both accounts in his Health Care Un-Covered newsletter before discussing them with MedPage Today. His advice was that patients should not treat an initial denial as the last word. He also said doctors and other health professionals may know more about how to challenge decisions, and suggested they could consider nontraditional escalation when a patient’s claim remains unresolved.
The routes to executive attention differed. Nicholas’s dispute had been reported in Vanity Fair before her email led to a response from a senior scientific officer. Grant sent a detailed appeal that cited medical and regulatory arguments and copied outside recipients. Those details matter: the report presents examples of prepared, escalated cases, not a test of a simple email sent without supporting documentation.
Healthcare policy advocate Eagan Kemp of Public Citizen told MedPage Today that patients and providers should not have to spend extensive time pursuing medically necessary care or tracking down executives. Kemp linked frustration with this process to growing support for Medicare-for-All, which he said would remove insurance middlemen. That is Kemp’s policy argument; the two cases themselves do not establish the effects of a different financing system.
“You can be certain that at big insurance companies, there is a group of people around the CEO who are dedicated to high-profile cases and cases that are elevated to the C-suite or to the PR department — and they get special attention.”
— Wendell Potter, former insurance company executive, speaking to MedPage Today
How Often Escalation Works
The report describes two successful cases, but provides no broader data on how many patients email insurance executives, how many receive a response, or how often an escalation changes a denial. It is also unclear whether either patient’s outcome would have been different without media attention, detailed advocacy or other factors in the review.
The article does not provide the insurers’ explanations for the original decisions or further detail on how the approvals were reached. It also does not establish whether the companies changed their policies after the cases. Potter’s warning about possible network consequences for doctors is his assessment; the report does not document such a consequence in either patient’s case.
Formal Appeals Remain Relevant
No additional company policy changes or follow-up actions are identified in the report. The immediate next step for patients with similar disputes remains case-specific: the two accounts show that executive contact was followed by approval, but they do not establish a standard process or a reliable outcome for others. The report offers no new deadline or formal procedure for contacting insurer leadership.
Potter said patients and clinicians should not accept an initial “no” as final, while acknowledging the strategy should not be necessary. Any wider assessment of its value would require information about unsuccessful as well as successful escalations, along with clearer evidence about how insurers review those cases.
Key Questions
What happened in the two cases?
Both patients received approval after contacting insurance company leaders about disputes. Nicholas’s insurer approved recommended chemotherapy after she emailed its CEO. UnitedHealthcare approved Grant’s surgery with an out-of-network surgeon at the in-network rate after he sent a detailed appeal to UnitedHealth Group’s CEO and others.
Does emailing an insurance CEO guarantee approval?
No. The report describes two successful examples and gives no data showing how often executive emails lead to a changed decision. It does not establish that this approach works for other patients or replaces established appeal channels.
What support did Grant use for his appeal?
Grant used Claimable, an AI-assisted appeal platform, to help prepare an 11-page submission. It argued that no in-network surgeon had comparable qualifications and cited relevant regulations, according to MedPage Today.
What risk did Potter identify for doctors?
Potter said insurers could be annoyed by doctors who repeatedly challenge decisions and warned that a physician could be removed from an insurer’s network. The report does not say that happened to either patient’s clinicians.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
